
X
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
https://pharmaphorum.com/news/ionis-deal-delivers-for-gsk-as-hbv-drug-hits-the-mark-in-phase-2/
Onpattro will cost $450,000 a year
Biotech insists drug for rare inherited disorder is still approvable.